Physiomics (PYC) Stock Chart & Stock Price History GBX 0.70 -0.05 (-6.67%) (As of 12/20/2024 11:42 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Physiomics Stock Price Performance 5 Day Performance-12.50%1 Month Performance+1.16%3 Month Performance+3.70%6 Month Performance-44.00%Year-To-Date Performance-56.25%1 Year Performance-54.66% Receive PYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. Email Address Forced out of retirement by these trades (Ad)You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedMake sure to check out Gamma Pockets HERE while it’s still widely available PYC Stock Chart for Sunday, December, 22, 2024 PYC Chart by TradingView Physiomics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 0.71GBX 0.70-0.71%GBX 0.77GBX 0.7067,891 shs£1.42 million12/19/2024GBX 0.73GBX 0.71-3.16%GBX 0.77GBX 0.71429,345 shs£1.43 million12/18/2024GBX 0.80GBX 0.73-9.00%GBX 0.80GBX 0.73381,612 shs£1.48 million12/17/2024GBX 0.75GBX 0.80+6.67%GBX 0.80GBX 0.751.55 million shs£1.63 million12/16/2024GBX 0.80GBX 0.75-6.25%GBX 0.85GBX 0.752.05 million shs£1.52 million12/13/2024GBX 0.72GBX 0.80+11.42%GBX 0.85GBX 0.718.17 million shs£1.63 million Get the Latest News and Ratings for PYC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 0.70GBX 0.72+3.31%GBX 0.75GBX 0.693.26 million shs£1.46 million12/11/2024GBX 0.71GBX 0.70-1.42%GBX 0.71GBX 0.70388,269 shs£1.41 million12/10/2024GBX 0.70GBX 0.71+0.86%GBX 0.73GBX 0.701.80 million shs£1.43 million12/09/2024GBX 0.73GBX 0.70-3.59%GBX 0.73GBX 0.681.96 million shs£1.42 million12/06/2024GBX 0.73GBX 0.73-0.55%GBX 0.75GBX 0.705.04 million shs£1.48 million12/05/2024GBX 0.65GBX 0.73+12.31%GBX 0.79GBX 0.6620.10 million shs£1.48 million12/04/2024GBX 0.65GBX 0.65GBX 0.66GBX 0.652.14 million shs£1.32 million12/03/2024N/AGBX 0.65GBX 0.68GBX 0.65251,407 shs£1.32 million11/29/2024GBX 0.65GBX 0.66+0.92%GBX 0.70GBX 0.66371,662 shs£1.33 million11/28/2024GBX 0.68GBX 0.65-3.70%GBX 0.68GBX 0.65401,357 shs£1.32 million11/27/2024GBX 0.67GBX 0.68+1.20%GBX 0.69GBX 0.67805,714 shs£1.37 million11/26/2024GBX 0.65GBX 0.67+2.62%GBX 0.70GBX 0.6762,000 shs£1.36 million11/25/2024GBX 0.68GBX 0.65-3.70%GBX 0.68GBX 0.652 shs£1.32 million11/22/2024GBX 0.68GBX 0.69+2.52%GBX 0.69GBX 0.6850,000 shs£1.41 million11/21/2024GBX 0.67GBX 0.68+1.05%GBX 0.70GBX 0.68174,292 shs£1.37 million Related Companies Fusion Antibodies Stock Chart Roquefort Therapeutics Stock Chart IXICO Stock Chart Genflow Biosciences Stock Chart ImmuPharma Stock Chart Oxford BioDynamics Stock Chart Destiny Pharma Stock Chart BSF Enterprise Stock Chart Theracryf Stock Chart Ovoca Bio Stock Chart Receive PYC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Physiomics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:PYC) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.